Abstract
Reactivation of herpes simplex virus (HSV) appears to play a significant role in oral mucositis resulting from bone marrow transplantation. The acyclic guanosine derivative acyclovir has been shown to be effective in treating and protecting against HSV infection in this group. The purpose of this study was to determine the role of HSV reactivation in oral mucositis in patients undergoing bone marrow transplantation who were seronegative for HSV or who received acyclovir prophylaxis. The results suggest that HSV plays an insignificant role in oral mucositis in these patients.
Original language | English (US) |
---|---|
Pages (from-to) | 680-683 |
Number of pages | 4 |
Journal | Oral Surgery, Oral Medicine, Oral Pathology |
Volume | 67 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1989 |
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Dentistry(all)